7*24 Hotline：
Sanjing pharmaceutical was founded in 1950. It mainly produced muscle and intravenous water injections in the early stage. It was the first enterprise in Heilongjiang Province to professionally produce water injections and the first domestic enterprise to introduce foreign water injections production equipment. It was one of the earliest pharmaceutical enterprises to pass the national GMP certification. The company now covers an area of 1.1 million square meters and employs nearly 6000 people. It is a comprehensive pharmaceutical enterprise focusing on OTC products, prescription drugs and health food, as well as pharmaceutical raw materials and preparations. In 2004, the "three fine" brand was recognized as "well-known protection" by the State Administration for Industry and commerce. On May 13, 2011, in the "2011 China's most valuable brand evaluation", the brand value of "Sanjing" was 6.893 billion yuan.
At present, Sanjing pharmaceutical has 15 subsidiaries, including 8 Industrial subsidiaries, 5 Commercial subsidiaries and 2 other related industrial subsidiaries. Up to now, 13 dosage forms of oral liquid, oral solution, small volume injection (non final sterilization), lyophilized powder injection, tablet, powder injection, capsule, granule, mixture, syrup, lotion, tea preparation, powder, sterile API (fosfomycin sodium, Yanhuning) and API (lacidipine, roxatidine hydrochloride acetate) have passed the 2010 GMP certification. Among them, the annual production capacity of oral liquid dosage form products is 1.6 billion. The company's leading products include calcium gluconate oral solution, zinc gluconate oral solution, Shuanghuanglian oral solution, sileping tablets, etc. In recent years, through the research and development of new drugs and health care products, we have constantly improved the product line and enriched the product lineup.
With more than 60 years of pharmaceutical experience, advanced technology and equipment, first-class management means and perfect scientific research and development system, the "three fine" brand enjoys a high reputation at home and abroad. Sanjing has always regarded products and services as its core competitiveness, and attached great importance to product R & D. in 2004, it built a relatively large-scale R & D center, which has become the research center of pharmaceutical engineering technology in Heilongjiang Province and the Key Laboratory of Western pharmaceutical preparations in Heilongjiang Province. It undertakes the major scientific and technological projects of "the Eleventh Five Year Plan" and "major new drug creation" -- new oral sustained and controlled release preparations and technology "Platform" project and "12th Five Year Plan" major scientific and technological special project of "major new drug creation" -- Research and development of anti Alzheimer's disease drug kabalatin bitartrate and its capsules "project. In 2008, the company became "the first batch of national innovative enterprises", and in 2012, it was selected as a key high-tech enterprise under the national torch plan. The company has also won the national quality management advanced enterprise, the national contract abiding and trustworthy enterprise, the national pharmaceutical system excellent enterprise, the national "May 1st Labor Award" advanced collective, "the national enterprise culture outstanding achievement award", "the national pharmaceutical industry pharmaceutical quality integrity construction demonstration enterprise", "21315 International quality credit AAA +", "China excellent integrity enterprise", and "national quality credit AAA +" "Top 100 comprehensive strength enterprises in China's chemical pharmaceutical industry" and "outstanding enterprise award of scientific and technological innovation" in Heilongjiang Province.
oil wellhead